Sage Therapeutics, Inc.
SAGE · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,652 | -$62,214 | -$95,778 | -$93,551 |
| Dep. & Amort. | -$442 | -$981 | $129 | $255 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,733 | $6,927 | $9,432 | $14,207 |
| Change in WC | $25,435 | -$25,435 | $20,758 | -$1,178 |
| Other Non-Cash | -$42,764 | -$25 | -$1,101 | -$2,098 |
| Operating Cash Flow | -$58,690 | -$81,728 | -$66,560 | -$82,365 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$68,602 | -$87,973 | -$88,704 | -$102,317 |
| Inv. Sales/Matur. | $149,620 | $133,756 | $135,278 | $183,371 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $81,018 | $45,783 | $46,574 | $81,054 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $3 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$65 | $148 | -$2 | $1,036 |
| Financing Cash Flow | -$65 | $148 | -$2 | $1,037 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $22,263 | -$35,797 | -$19,988 | $1,226 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,674 | $82,471 | $102,459 | $101,233 |
| End Cash | $68,937 | $46,674 | $82,471 | $102,459 |
| Free Cash Flow | -$58,690 | -$81,728 | -$66,560 | -$82,365 |